INTRAPERITONEAL CHEMOTHERAPY
- 1 March 1994
- journal article
- Published by Elsevier in Obstetrics and Gynecology Clinics of North America
- Vol. 21 (1) , 195-212
- https://doi.org/10.1016/s0889-8545(21)00316-8
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancerThe Lancet, 1992
- Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaGynecologic Oncology, 1992
- Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.Journal of Clinical Oncology, 1992
- Intraperitoneal chemotherapy: Analysis of complications with an implanted subcutaneous port and catheter systemGynecologic Oncology, 1991
- Effects of intraperitoneal chemotherapy on anastomotic healing in the ratJournal of Surgical Research, 1991
- A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: A Gynecologic Oncology Group StudyGynecologic Oncology, 1990
- A phase I–II trial of intraperitoneal cisplatin and α-lnterferon in patients with persistent epithelial ovarian cancerGynecologic Oncology, 1990
- A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1989
- Pharmacokinetics of carboplatin after intraperitoneal administrationCancer Chemotherapy and Pharmacology, 1988
- Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosisGynecologic Oncology, 1986